Published Date : 06 Feb 2023
The global in vitro fertilization market size was exhibited at USD 17.04 billion in 2022 and is projected to hit around USD 33 billion by 2030, growing at a CAGR of 8.6% during the forecast period 2022 to 2030.
In a in vitro fertilization process, an egg fertilizes from a woman outside her body. It is a complex series of procedures that helps in fertility. It prevents genetic problems and aid with the conception of a child. The mature eggs are fertilized by sperm in a lab. After this, the fertilized egg is transferred to the uterus. This whole process takes about three weeks. It is an effective form of assisted reproductive technology. It can also be done using a couple's sperm and eggs. You can have a healthy baby using IVF. However, it depends upon many factors, such as your age and the cause of infertility. This process can be time-consuming, expensive, and invasive. It is done to treat infertility. It is a primary treatment for infertility in women over age 40. It is done if any partner has Fallopian tube damage or blockage, Ovulation disorders, Endometriosis, Uterine fibroids, Previous tubal sterilization or removal, Impaired sperm production or function, Unexplained infertility, genetic disease, or Fertility preservation for cancer or other health conditions.
In this, special medical techniques are used. There are five steps involved in vitro fertilization. These are superovulation, egg retrieval, Insemination and fertilization, embryo culture, and embryo transfer. It can utilize your eggs and your partner's sperm, your eggs and donator sperm, donor eggs and your partner's sperm, donor eggs, donor sperm, and donated embryos. A person who has infertility has to go through in vitro fertilization. Before in vitro fertilization, a woman must undergo ovarian reserve testing. The level of follicle-stimulating hormone (FSH) is tested. Men have to go through sperm testing. The number, size, and shape of the sperm are analyzed.
The global in vitro fertilization market is majorly driven by the increasing repro tourism. In line with this, the rising cases of male and female infertility is a key factor driving the market growth. Furthermore, infertility is suffered by many individuals globally. The average age of getting married and having the first child is rising. The number of women seeking In Vitro Fertilization (IVF) treatment has increased. Many women freeze their eggs to focus on their careers and have a baby at a later stage. The growing demand for fertility treatments stimulates market growth. The rise in the adoption of IVF procedures and the increasing success rate of IVF techniques catalyzes market growth.
The onset of the COVID-19 pandemic adversely affected the market as fertility treatments were suspended. Public and private organizations are spreading awareness about infertility, infertility treatment, and their services. The increasing male infertility, declining fertility rates, rising consumption of alcohol, and growing obesity positively influence market growth. The rising awareness regarding infertility and the advent of advanced treatment options fuels market growth. The increased awareness regarding contraceptives boosts the overall market growth. The delayed pregnancy after marriage propels the market growth. The decline in fertility rates across the globe drives the market growth. All these factors drive the growth of the global in-vitro fertilization market.
In Vitro Fertilization Market Report Scope:
|Market Size in 2023||USD 18.49 Billion|
|Market Size by 2030||USD 33 Billion|
|Growth Rate from 2022 to 2030||CAGR of 8.6%|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2022 to 2030|
|Segments Covered||By Product, and By End User|
|Regions Covered||North America, Europe, Asia-Pacific, Latin America and Middle East & Africa|
Based on the product type, fresh non-donor dominated the market due to the high success rate, easy implantation, and higher birth rates. The growing demand for fresh non-donor cycles and the rising infertility rates drive the segment's growth. The frozen non-donor is expected to witness a promising CAGR due to the higher pregnancy rates and low cost.
Based on the end user, fertility clinics dominated the market due to the increasing number of fertility clinics across the globe. The fertility clinics are preferred by couples and offer specialized care services related to their pregnancy and fertility problems. The rising awareness regarding fertility clinics fuels the growth of the fertility clinics segment across the globe. Hospitals are expected to witness a promising CAGR due to the widespread penetration of the hospitals. The advanced healthcare infrastructure and the presence of advanced healthcare professionals catalyze market growth. The launch of advanced surgical tools and equipment boosts the hospital segment's growth.
Based on the region, Europe dominated the market due to rising medical tourism. The legal revisions related to IVF techniques drive market growth across the region. On the other hand, Asia Pacific is expected to witness a promising CAGR due to rapidly declining fertility rates and the presence of a huge population. The government Initiatives, the increasing number of women giving preference to careers, and rising awareness regarding fertility clinics and procedures catalyze market growth across the region. The growing awareness among the population regarding in-vitro fertilization propels the market growth.
The increasing healthcare and adoption of advanced reproductive technology favor market growth. The rising medical tourism strengthens market growth. North America is witnessing a reduction in fertility rates among men and women. The increasing prevalence of polycystic ovary syndrome, the emergence of fertility clinics, favorable reimbursement policies of the government, and growing healthcare expenditure are driving market growth across the region. The rising obesity rates, delayed marriage, and increasing consumption of alcohol favor market growth.
Market Driver: Rising prevalence of infertility
The rising prevalence of infertility significantly contributes to market growth across the globe. In line with this, the rising adoption of the IVF technique and the growing popularity of IVF & ICSI treatment positively influences the demand for in vitro fertilization treatment during the forecast period. The surging success rate of IVF procedures and escalating awareness about infertility are growth-inducing factors. The introduction of intracytoplasmic sperm injection (ICSI) drives the growth of in vitro fertilization (IVF) market. The delay in pregnancy accelerates market growth. The increase in the median age of women for first-time pregnancy propels market growth. Several complications associated with pregnancy and the risk of infertility in female favors market growth. The rising stress level and obesity, and the prevalence of a sedentary lifestyle are leading to an increasing prevalence of infertility.
Market Opportunity: Government Initiatives
Governments across various countries are taking initiatives to provide better reimbursement policies for in vitro fertilization treatment. This is expected to offer numerous opportunities for market growth. The increasing awareness about infertility catalyzes market growth. The availability of different treatments across the globe propels market growth. The increasing male infertility, the rising government initiatives to enhance IVF treatment, and the growing consumption of alcohol and cigarettes favor market growth. The growing awareness about the availability of treatment options creates a positive outlook for the market.
Market Restraint: High costs
The high costs of in vitro fertilization treatment restrict market growth. More than a million in vitro fertilization treatments are conducted every year. The cost of treatment is different in different countries. The lack of proper healthcare reimbursement policies further hampers market growth. The poor reimbursement policies and the lack of insurance coverage impede the market growth.
Market Challenge: Lower efficacy of infertility treatment
The lower effectiveness of infertility treatment challenges the in vitro fertilization market growth. The number of older age women seeking pregnancy is increasing. The complications and risks also increase with age. The reduced success rate of in vitro fertilization in older women hampers the market growth.
In January 2021, Merck KGaA partnered with Royal Philips to develop a digital solution for providing personalized fertility treatment.
In January 2020, Merck KGaA received approval for its GONALI-f pen from the European Commission.
Market Key Players:
By Product Type
By End User
Buy this Research Report@ https://www.precedenceresearch.com/checkout/1501
You can place an order or ask any questions, please feel free to contact at firstname.lastname@example.org| +1 9197 992 333